Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
11/2013
11/07/2013US20130296338 Quinoline and Quinoxaline Derivatives as Kinase Inhibitors
11/07/2013US20130296333 Hedgehog pathway modulators
11/07/2013US20130296330 Macrocyclic integrase inhibitors for use in the treatment of feline immunodeficiency virus
11/07/2013US20130296320 Novel bicyclic compound or salt thereof
11/07/2013US20130296319 N1-PYRAZOLOSPIROKETONE ACETYL-CoA CARBOXYLASE INHIBITORS
11/07/2013US20130296312 Preparation and Uses of 1,2,4-Triazolo [1,5a] Pyridine Derivatives
11/07/2013US20130296311 Inhibitors of hcv ns5a
11/07/2013US20130296309 Aryl pyridine as aldosterone synthase inhibitors
11/07/2013US20130296307 1h-pyrazolo[3,4-b]pyridines and therapeutic uses thereof
11/07/2013US20130296302 1h-pyrazolo[3,4-b]pyridines and therapeutic uses thereof
11/07/2013US20130296300 Quinolines and aza-quinolines as crth2 receptor modulators
11/07/2013US20130296299 PYRROLO[2,3-b]PYRIDIN-4-YL-AMINES AND PYRROLO[2,3-b]PYRIMIDIN-5-YL-AMINES AS JANUS KINASE INHIBITORS
11/07/2013US20130296293 1,3,4-oxadiazole and 1,3,4-thiadiazole beta-lactamase inhibitors
11/07/2013US20130296292 1,3,4-oxadiazole and 1,3,4-thiadiazole beta-lactamase inhibitors
11/07/2013US20130296291 1,3,4-oxadiazole and 1,3,4-thiadiazole beta-lactamase inhibitors
11/07/2013US20130296290 1,3,4-oxadiazole and 1,3,4-thiadiazole beta-lactamase inhibitors
11/07/2013US20130296281 Aryl Substituted Indoles and Their Use as Blockers of Sodium Channels
11/07/2013US20130296275 Oxazolidinone-quinolone hybrid antibiotics
11/07/2013US20130295051 Novel compounds and compositions for the inhibition of nampt
11/07/2013US20130292653 Condensed-cyclic compound and organic light-emitting diode comprising the same
11/06/2013EP2660243A2 Substituted hydrogenated thieno-pyrrolo[3,2-c]pyridine, ligands, a pharmaceutical composition and a method for using the above
11/06/2013EP2660241A2 C-17-heteroaryl steroidal compounds as inhibitors of cyp11b, cyp17, and/or cyp21
11/06/2013EP2659528A1 Perylene-based semiconductors and methods of preparation and use thereof
11/06/2013EP2658856A1 Mesoionic pyrido [1,2 -a]pyrimidine pesticides
11/06/2013EP2658844A1 Novel pyrimidine derivatives, preparation thereof, and pharmaceutical use thereof as akt(pkb) phosphorylation inhibitors
11/06/2013EP2658380A1 Arthropod pest control composition and method for controlling arthropod pests
11/06/2013EP2658379A1 Arthropod pest control composition and method for controlling arthropod pests
11/06/2013CN103384669A Bicyclic inhibitors of ALK
11/06/2013CN103384668A Novel compounds and compositions for the inhibition of NAMPT
11/06/2013CN103384667A Benzoxazepines asn inhibitors of P13k/mTOR and methods of their use and manufacture
11/06/2013CN103382178A Condensed-cyclic compound and organic light-emitting diode comprising the same
11/06/2013CN102066358B Piperidine derivatives as CGRP receptor antagonists
11/06/2013CN101932581B Compound having substituted pyridyl group and pyridoindole ring structure linked through phenylene group, and organic electroluminescent device
11/06/2013CN101903385B 4-aminopyrimidine derivatives as histamine H4 receptor antagonists
11/06/2013CN101899006B 2,4,5-trisubstituted imidazoles and their use as anti-microbial agents
11/06/2013CN101796051B Substituted heterocycle fused gamma-carbolines synthesis
11/06/2013CN101679425B 6-(pyrrolopyridinyl)-pyrimidine-2-yl-amine and its uses in treating cancer and AIDS
11/06/2013CN101679399B Novel carbamoyloxy arylalkanoyl arylpiperazine compound, pharmaceutical compositions comprising the compound and method for treating pain, anxiety and depression by administering the compound
11/06/2013CN101663300B Compound wherein substituted bipyridyl group is connected with pyridoindole ring structure through phenylene group, and organic electroluminescent device
11/06/2013CN101484544B Liquid hardening
11/06/2013CN101010302B Sigma receptor inhibitors
11/05/2013US8575337 Oxazolidinone derivative having fused ring
11/05/2013US8575336 Indazoles
11/05/2013US8575335 Method of preparing nitrogen-doped graphene and nitrogen-doped graphene prepared thereby
11/05/2013US8575186 Epiminocycloalkyl[b] indole derivatives as serotonin sub-type 6 (5-HT6) modulators and uses thereof
11/05/2013US8575178 Isothiazolo-pyrimidinedione derivatives as TRPA1 modulators
11/05/2013US8575152 Non-steroidal compounds useful as glucocorticoid receptor modulators
11/05/2013US8575145 Triazolopyridine compounds as PIM kinase inhibitors
10/2013
10/31/2013WO2013163190A1 Dna-pk inhibitors
10/31/2013WO2013163109A1 Intermediates and processes for preparing compounds
10/31/2013WO2013163022A1 Blue luminescent compounds
10/31/2013WO2013163019A1 Blue luminescent compounds
10/31/2013WO2013162757A1 Cytotoxic-drug delivering molecules targeting hiv (cdm-hs), cytotoxic activity against the human immunodeficiency virus and methods of use
10/31/2013WO2013161913A1 Nitrogenated heterocyclic compound
10/31/2013WO2013161904A1 Sulfonamide derivative and medicinal use thereof
10/31/2013WO2013161312A1 Pyrrolopyridinone derivatives as ttx-s blockers
10/31/2013WO2013160875A1 Process for manufacturing naphthyridine derivatives
10/31/2013WO2013159427A1 Method for preparing pyronaridine
10/31/2013WO2013111118A3 Diaziridines for treating neurodegenerative disorders
10/31/2013WO2013111117A3 Diaziridines for treating neurodegenerative disorders
10/31/2013US20130289280 Novel pharmaceutical forms, and methods of making and using the same
10/31/2013US20130289275 Process for the preparation of praziquantel
10/31/2013US20130289064 Salts and crystall forms of 2-methyl-2-[4-(3-methyl-2-oxo-8-quinolin-3-yl-2,3-dihydro-imidazo[4,5-c]quinolin-1-yl)-phenyl]-propionitrile
10/31/2013US20130289052 Arthropod pest control composition and method for controlling arthropod pests
10/31/2013US20130289046 Pharmaceutical formulations of substituted azaindoleoxoacetic piperazine derivatives with protease inhibitors
10/31/2013US20130289041 Quinoxaline compounds and uses thereof
10/31/2013US20130289038 2-arylimidazole derivatives as pde10a enzyme inhibitors
10/31/2013US20130289029 Fused Ring Compound For Use As Mineralocorticoid Receptor Antagonist
10/31/2013US20130289020 CXCR4 Receptor Antagonists
10/31/2013US20130289015 N-containing heteroaryl derivatives as jak3 kinase inhibitors
10/31/2013US20130289013 IMIDAZO[1,2-a]PYRIDINE COMPOUNDS
10/31/2013US20130289012 1,2,4-oxadiazole and 1,2,4-thiadiazole beta-lactamase inhibitors
10/31/2013US20130289004 Anti-staphylococcal celecoxib derivatives
10/31/2013US20130287687 Compounds, compositions, methods of synthesis, and methods of treatment
10/31/2013DE59209330C5 Benzimidazole, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung Benzimidazoles, pharmaceutical compositions containing them and methods for their preparation
10/30/2013EP2657303A1 Near-infrared absorbing synthetic resin composition
10/30/2013EP2657235A1 Compound containing basic group and use thereof
10/30/2013EP2657234A1 Optically-active diazabicyclooctane derivative and method for manufacturing same
10/30/2013EP2657233A1 3,5-disubstituted alkynylbenzene compound and salt thereof
10/30/2013EP2657225A2 Substituted methyl amines, serotonin 5-ht6 receptor antagonists, methods for the production and use thereof
10/30/2013EP2655372A2 Pyrroloquinolinyl-pyrrolidine-2,5-dione compositions and methods for preparing and using same
10/30/2013EP2655371A1 Pyrazolopiperidine compounds as ccr1 receptor antagonists
10/30/2013EP2655370A1 Compositions and methods for modulating fxr
10/30/2013EP2655366A1 Naphtalene monoimide derivatives and use thereof as photosensitizers in solar cells and photodetectors
10/30/2013EP2655362A1 Hepatitis c inhibitors and uses thereof
10/30/2013EP2655356A1 Faah inhibitors
10/30/2013EP2655342A1 Heterocyclic compounds and their uses
10/30/2013EP2655337A1 Fused heterocyclic compound and use for pest control thereof
10/30/2013EP2655314A1 Multi- api loading prodrugs
10/30/2013EP2654748A1 Indazole derivatives useful as erk inhibitors
10/30/2013EP2654421A1 Fused heterocyclic indane carboxamide cgrp receptor antagonists
10/30/2013CN103380119A Substituted aminobutyric derivatives as neprilysin inhibitors
10/30/2013CN103374041A Lewis acid mediated synthesis of cyclic esters
10/30/2013CN103374021A Zinc binding group containing pyridopyrimidin inhibitor for HDAC (Histone Deacetylase) and mTOR (Mammalian Target of Rapamycin)
10/30/2013CN103374017A Trivalent chiral nitrogen compound and application thereof
10/30/2013CN103374000A Pyrimido diazepine compound as well as pharmaceutical composition and application thereof
10/30/2013CN103373998A Extraction process of sophocarpidine
10/30/2013CN103373997A Zinc binding group containing pyridonaphthyridine inhibitor for HDAC (Histone Deacetylase) and mTOR (Mammalian Target of Rapamycin)
10/30/2013CN103373996A Bicyclic derivatives serving as CRTH2 receptor antagonist
10/30/2013CN103373995A Method for preparing pyronaridine
1 ... 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 ... 646